Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include
hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is …

Metabolic syndrome (MetS) is a leading public health and clinical challenge worldwide.
MetS represents a group of interrelated risk factors that predict cardiovascular diseases …

The growing prevalence of metabolic syndrome (MetS) in the US and even worldwide is
becoming a serious health problem and economic burden. MetS has become a crucial risk …

Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide,
especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia …

The metabolic syndrome refers to the co-occurrence of several known cardiovascular risk
factors, including insulin resistance, obesity, atherogenic dyslipidemia and hypertension …

Obesity is reaching epidemic proportions with recent worldwide figures estimated at 1.4
billion and rising year‐on‐year. Obesity affects all socioeconomic backgrounds and …

The metabolic syndrome (MetS) is defined as the concurrence of obesity-associated
cardiovascular risk factors including abdominal obesity, impaired glucose tolerance …

Metabolic syndrome (MetS) is a bunch of metabolic defects comprising hypertension, insulin
resistance, visceral obesity, fatty liver, and atherogenic cardiovascular diseases. Lifestyle …

The metabolic syndrome is a cluster of interrelated common clinical disorders, including
obesity, insulin resistance, glucose intolerance, hypertension, and dyslipidemia …